Select Page

Additional FDA-cleared measurements of Cardiac Output and Single-Lead ECG

Remote Monitoring

Post-Discharge Monitoring

Clinic Monitoring

Additional FDA-cleared measurements of Cardiac Output and Single-Lead ECG

Remote Monitoring

Post-Discharge Monitoring

Clinic Monitoring

The CoVa™ Monitoring System 2 (CoVa™ 2)

CoVa™ 2 is a low-cost, easy-to-use monitoring system featuring three primary components: Necklace (a body-worn sensor), Gateway, and Web-based System. The Necklace measures vital signs, complex hemodynamic parameters, and time-dependent physiological waveforms. It sends this information to several different Gateways, which receive and forward it to a Web-based System for clinical review.

FDA-cleared Measurements

Stroke Volume
Stroke volume is the amount of milliliters of blood pumped from the heart with each beat.
Cardiac Output
Cardiac output is the amount of liters of blood pumped from the heart each minute.
Chest Fluids
Chest fluids, or thoracic impedance, represent a measurement of the volume of fluids present in the chest. Lower values indicate possible retention of fluids.
Single-Lead ECG
Single-lead ECG describes the electrical activity of the heart.
Heart Rate
Heart rate is the number of times (per minute) that the heart beats.
Heart Rate Variability
Heart rate variability is the beat-to-beat variation between heart beats.
Respiration
Respiration rate is the number of breaths taken per minute.

Necklace

The Necklace drapes around a patient’s neck and attaches to their chest with two disposable electrodes. Small magnets attach electrodes to the Necklace for ease of use. The Necklace measures ECG and impedance waveforms, and from these and other signals calculates heart rate, heart rate variability, respiration rate, skin temperature, thoracic impedance (a proxy for fluids), stroke volume and cardiac output. Measurements take less than 5 minutes, after which the Necklace sends information via Bluetooth® to the Gateway.

Gateway

The Gateway receives Necklace-generated information, and forwards it to the Web-based System via WiFi or cellular systems. Current Gateways include Android-based tablets or smart phones featuring touch-panel displays, or a ‘black-box’ device that does not require any user interaction.

Web-based System

The Web-based System receives and displays information from the Gateway, and seamlessly forwards it to external customer systems, electronic medical records, or remote monitoring portals. In this way, the Web-based System supports a variety of monitoring experiences.

Applications

Remote Patient Monitoring

CoVa™ 2 makes at-home monitoring of cardiopulmonary parameters for heart failure (HF) patients as simple as glucose monitoring for diabetics. Current solutions for this patient population are relegated to technologies such as weight scales, which are insensitive to physiological parameters and unable to characterize early onset of HF. Weight is a late indicator of a potential heart failure event; in contrast, measurements of fluid level, stroke volume, and cardiac output are relatively early indicators. CoVa™ 2 avails physiological information to physicians, caregivers, and loved ones.

Post-Discharge Monitoring

CoVa™ 2 can monitor patients during the transition from hospital to home. This allows clinicians to discharge patients from the hospital earlier with additional clinical oversight, and remotely check-in on high-risk patients to identify decompensation.

Clinic Monitoring

CoVa™ 2 can monitor patients during their visit to a medical clinic. In this application, clinical professionals can quickly diagnose, triage, and develop treatment plans for patients, even while they are in the waiting room.